Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Increases By 44.1%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 377,600 shares, an increase of 44.1% from the December 15th total of 262,000 shares. Based on an average daily volume of 1,060,000 shares, the days-to-cover ratio is presently 0.4 days. Currently, 11.0% of the company’s stock are short sold.

China SXT Pharmaceuticals Trading Up 4.4 %

Shares of NASDAQ SXTC traded up $0.02 during midday trading on Thursday, hitting $0.41. The stock had a trading volume of 85,490 shares, compared to its average volume of 813,889. The business’s 50 day moving average is $0.42 and its 200-day moving average is $0.68. China SXT Pharmaceuticals has a 52 week low of $0.30 and a 52 week high of $3.37.

About China SXT Pharmaceuticals

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read More

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.